Literature DB >> 26493984

Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.

Vanessa Szablewski1, Céline René2, Valérie Costes3.   

Abstract

Patients with common variable immunodeficiency disorder (CVID) are subject to lymphoproliferative disorders and predisposed to lymphoma. Some patients may also develop liver lesions. The purpose of this study was to define clinical and histopathological features of patients with CVID presenting with liver lesions suspicious of lymphoma. Four CVID cases corresponding to these criteria were retrieved from our files. Liver biopsy specimens were subjected to morphologic, immunophenotypic and molecular analysis. All patients presented with hepatosplenomegaly and two furthermore with lymphadenopathy. The clinical working diagnosis in the four cases was lymphoma. All liver biopsies revealed nodular regenerative hyperplasia (NRH), associated with mild to marked sinusoid lymphocytic infiltrate consisting of "activated" cytotoxic T cells (CD8+, Tia1+, granzyme B+, TCRβF1+, CD56-). EBER was negative in all cases. T cell clonality was found in one of the two interpretable cases. All patients had an indolent course and clinical symptoms regressed with immunoglobulin replacement. This study suggests that indolent proliferation in the liver sinusoid of cytotoxic T cell associated with NRH is a specific liver lesion in the context of CVID. In CVID patients clinically suspected of lymphoma, pathologists should avoid a misdiagnosis of aggressive T cell lymphoma with a risk of over treatment.

Entities:  

Keywords:  Cytotoxic; Immunodeficiency; Lymphoproliferative; Nodular regenerative hyperplasia; T cells

Year:  2015        PMID: 26493984     DOI: 10.1007/s00428-015-1862-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?

Authors:  Tony Petrella; Eve Maubec; Pascale Cornillet-Lefebvre; Rein Willemze; Michel Pluot; Anne Durlach; Eduardo Marinho; Jean-Luc Benhamou; Patty Jansen; Alistair Robson; Florent Grange
Journal:  Am J Surg Pathol       Date:  2007-12       Impact factor: 6.394

2.  Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia.

Authors:  Barun Kumar Lal; Adrian Stanley
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

Authors:  Anamarija M Perry; Roger A Warnke; Qinglong Hu; Philippe Gaulard; Christiane Copie-Bergman; Serhan Alkan; Huan-You Wang; Jason X Cheng; Chris M Bacon; Jan Delabie; Erik Ranheim; Can Kucuk; Xiaozhou Hu; Dennis D Weisenburger; Elaine S Jaffe; Wing C Chan
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

4.  In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.

Authors:  Peijie Cong; Mark Raffeld; Julie Teruya-Feldstein; Lynn Sorbara; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

Review 5.  Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.

Authors:  Sham Mailankody; Esther Mena; Constance M Yuan; Arun Balakumaran; W Michael Kuehl; Ola Landgren
Journal:  Leuk Lymphoma       Date:  2010-10-20

6.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

7.  Hepatitis in common variable immunodeficiency.

Authors:  Jason A Daniels; Michael Torbenson; Perumal Vivekanandan; Robert A Anders; John K Boitnott
Journal:  Hum Pathol       Date:  2008-12-11       Impact factor: 3.466

Review 8.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.

Authors:  Helen Chapel; Charlotte Cunningham-Rundles
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

9.  Clinical characteristics and outcomes of primary antibody deficiency: a 20-year follow-up study.

Authors:  Hung-Yi Chan; Yao-Hsu Yang; Hsin-Hui Yu; Yin-Hsiu Chien; Li-Lan Chiang; Bor-Luen Chiang
Journal:  J Formos Med Assoc       Date:  2012-08-11       Impact factor: 3.282

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  6 in total

Review 1.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency.

Authors:  Anna-Maria Globig; Valentina Strohmeier; Rambabu Surabattula; Diana J Leeming; Morten A Karsdal; Maximilian Heeg; Gerhard Kindle; Sigune Goldacker; Caroline von Spee-Mayer; Michele Proietti; Birke Bausch; Dominik Bettinger; Michael Schultheiß; Robert Thimme; Detlef Schuppan; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2022-07-11       Impact factor: 8.542

3.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

Review 4.  State-of-the-art diagnostic evaluation of common variable immunodeficiency.

Authors:  Theodore K Lee; Jessica D Gereige; Paul J Maglione
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-11       Impact factor: 6.248

5.  Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency.

Authors:  Bertram Bengsch; Klaus Warnatz; Adam Klocperk; David Friedmann; Alexandra Emilia Schlaak; Susanne Unger; Zuzana Parackova; Sigune Goldacker; Anna Sediva
Journal:  J Clin Immunol       Date:  2022-05-19       Impact factor: 8.542

Review 6.  Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders.

Authors:  Antonio Pecoraro; Ludovica Crescenzi; Gilda Varricchi; Giancarlo Marone; Giuseppe Spadaro
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.